Amarandi, R.-M.; Ibanescu, A.; Carasevici, E.; Marin, L.; Dragoi, B.
Liposomal-Based Formulations: A Path from Basic Research to Temozolomide Delivery Inside Glioblastoma Tissue. Pharmaceutics 2022, 14, 308.
https://doi.org/10.3390/pharmaceutics14020308
AMA Style
Amarandi R-M, Ibanescu A, Carasevici E, Marin L, Dragoi B.
Liposomal-Based Formulations: A Path from Basic Research to Temozolomide Delivery Inside Glioblastoma Tissue. Pharmaceutics. 2022; 14(2):308.
https://doi.org/10.3390/pharmaceutics14020308
Chicago/Turabian Style
Amarandi, Roxana-Maria, Alina Ibanescu, Eugen Carasevici, Luminita Marin, and Brindusa Dragoi.
2022. "Liposomal-Based Formulations: A Path from Basic Research to Temozolomide Delivery Inside Glioblastoma Tissue" Pharmaceutics 14, no. 2: 308.
https://doi.org/10.3390/pharmaceutics14020308
APA Style
Amarandi, R.-M., Ibanescu, A., Carasevici, E., Marin, L., & Dragoi, B.
(2022). Liposomal-Based Formulations: A Path from Basic Research to Temozolomide Delivery Inside Glioblastoma Tissue. Pharmaceutics, 14(2), 308.
https://doi.org/10.3390/pharmaceutics14020308